Hjem › Småcellet lungekreft › Michigan › Detroit
Kliniske studier for Småcellet lungekreft i Detroit, MI
12 studier for Småcellet lungekreft søker deltakere på steder i og rundt Detroit (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
RekruttererFase 2
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruttererFase 1/2
- Barbara Ann Karmanos Cancer Center, Detroit
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 1/2
- Karmanos Cancer Institute, Detroit
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RekruttererFase 3
- Henry Ford Health Cancer, Detroit
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
RekruttererFase 1
- Henry Ford Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Karmanos Cancer Institute, Detroit
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RekruttererFase 3
- Henry Ford Health System, Detroit
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
RekruttererFase 2
- Henry Ford Cancer- Detroit, Detroit
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
RekruttererFase 2
- Karmanos Cancer Center (Wayne State University), Detroit
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
RekruttererFase 2
- Henry Ford Health Saint John Hospital, Detroit
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Henry Ford Health System, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 129, Detroit
Småcellet lungekreft-studier i andre byer
- Houston, TX26 studier
- Arlington, VA23 studier
- New York City, NY22 studier
- Boston, MA21 studier
- Nashville, TN20 studier
- Los Angeles, CA20 studier
- Orlando, FL15 studier
- Dallas, TX13 studier
- Cleveland, OH13 studier
- Chicago, IL13 studier
- St. Louis, MO13 studier
- Washington, DC12 studier
Andre studier i Detroit
- Ikke-småcellet lungekreft44 studier
- Brystkreft33 studier
- Kreft (alle typer)29 studier
- Kolorektal kreft26 studier
- Eggstokkreft26 studier
- Metastatisk kreft24 studier
- Prostatakreft22 studier
- Endometriekreft21 studier
- Lungekreft20 studier
- Multipelt myelom19 studier
- Mavekreft16 studier
- Plateepitelcancer i hode og hals15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.